Cargando…
FGFBP1 as a potential biomarker predicting bacillus Calmette–Guérin response in bladder cancer
Accurate prediction of Bacillus Calmette–Guérin (BCG) response is essential to identify bladder cancer (BCa) patients most likely to respond sustainably, but no molecular marker predicting BCG response is available in clinical routine. Therefore, we first identified that fibroblast growth factor bin...
Autores principales: | Li, Fei, Zhang, Henghui, Wang, Yu, Yao, Zhihao, Xie, Kunfeng, Mo, Qixin, Fan, Qin, Hou, Lina, Deng, Fan, Tan, Wanlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478507/ https://www.ncbi.nlm.nih.gov/pubmed/36119059 http://dx.doi.org/10.3389/fimmu.2022.954836 |
Ejemplares similares
-
Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022) -
Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008) -
The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma
por: Yuan, Huiyang, et al.
Publicado: (2023) -
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020) -
Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)